Recent Articles

Endometrial Cancer Incidence Rising in the US and Worldwide

| November 20, 2017 | 0 Comments

Endometrial Cancer Incidence Rising in the US and Worldwide Diagnoses of endometrial cancer have increased worldwide in recent years, with rates rising in more than half of the 43 countries studied during the decade ending around 2010, a team of international researchers has shown. See Original Article

Continue Reading

Experimental Ovarian Cancer Vaccine Shows Promise in Mice

| November 17, 2017 | 0 Comments

Experimental Ovarian Cancer Vaccine Shows Promise in Mice The vaccine targets a protein found at elevated levels in about 90% of the most common type of ovarian cancer. If validated in human studies, researchers believe the vaccine may be particularly useful for women who carry BRCA1 and BRCA2 gene mutations.See Original Article

Continue Reading

Many Ovarian Cancers May Start in Fallopian Tubes, Study Finds

| November 15, 2017 | 0 Comments

Many Ovarian Cancers May Start in Fallopian Tubes, Study Finds A new study provides more evidence that the most common form of ovarian cancer may originate in the fallopian tubes, and that there is a window of nearly 7 years between development of fallopian tube lesions and the start of ovarian cancer.See Original Article

Continue Reading

Alternate Driver of Treatment-Resistant Prostate Cancer Identified

| November 14, 2017 | 0 Comments

Alternate Driver of Treatment-Resistant Prostate Cancer Identified Researchers have identified an emerging subtype of metastatic prostate cancer that is resistant to therapies that block hormones that fuel the disease.See Original Article

Continue Reading

Study Identifies Potential Drug Combination for Ewing Sarcoma

| November 9, 2017 | 0 Comments

Study Identifies Potential Drug Combination for Ewing Sarcoma From experiments in cells and mice, researchers have identified a two-drug combination that kills more Ewing sarcoma cells than either drug on its own. The study findings could help inform future clinical trials.See Original Article

Continue Reading

Liquid Biopsy: Using DNA in Blood to Detect, Track, and Treat Cancer

| November 8, 2017 | 0 Comments

Liquid Biopsy: Using DNA in Blood to Detect, Track, and Treat Cancer Research studies show tests that analyze tumor DNA in blood, called liquid biopsies, may help detect cancer early, guide precision cancer treatment, and tracking treatment response.See Original Article

Continue Reading

Study Tracks the Evolution of Treatment Resistance in Metastatic Breast Cancer

| November 7, 2017 | 0 Comments

Study Tracks the Evolution of Treatment Resistance in Metastatic Breast Cancer A new study suggests that the cells in treatment-resistant tumors in women with metastatic breast cancer share important characteristics that could potentially make tumors vulnerable to therapies that otherwise might not have been considered.See Original Article FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer The […]

Continue Reading

FDA Approves Cobimetinib as Part of Drug Combination for Advanced Melanoma

| November 5, 2017 | 0 Comments

FDA Approves Cobimetinib as Part of Drug Combination for Advanced Melanoma The FDA has approved the targeted drug cobimetinib, in combination with another targeted therapy, to treat patients with advanced melanoma whose tumors have specific genetic mutations.See Original Article Driving New Approaches to Cancer Prevention and Early Detection Researchers are pioneering new approaches to preventing […]

Continue Reading

New on NCI’s Websites for November 2017

| November 3, 2017 | 0 Comments

New on NCI’s Websites for November 2017 NCI periodically provides updates on new websites and other online content of interest to the cancer community.See Original Article

Continue Reading

Assuming the Role of NCI Director: Working to Accelerate Progress

| November 2, 2017 | 0 Comments

Assuming the Role of NCI Director: Working to Accelerate Progress Norman Sharpless, M.D., discusses his appointment as the director of the National Cancer Institute and his plans for continuing NCI’s long tradition of research excellence and commitment to improving people’s lives.See Original Article

Continue Reading